Tom Wilemon Archive
-
November 15, 2018
Immunotherapies linked to specific heart complications
In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that heart and vessel complications include myocarditis, pericarditis, vasculitis and arrhythmias, and that they occur early in the course of treatment. -
November 8, 2018
Clinical fellows program bolstered by new NCI grant
A new grant from the National Cancer Institute (NCI) will fund an intensively mentored training experience for clinical fellows at Vanderbilt University Medical Center for the next five years. -
November 8, 2018
Multi-factor authentication coming for C2HR users
Like employees the world over, Vanderbilt University Medical Center email system users are prey to frequent email spoofs, by which would-be identity thieves attempt to steal employee login credentials. -
November 2, 2018
Cancer Center among best in nation for stem cell transplant survival
Vanderbilt-Ingram Cancer Stem Cell Transplant ranks among the best in the nation for donor stem cell transplant survival rates among large centers, according to an annual report. -
November 1, 2018
Warner’s medical informatics research recognized
Jeremy Warner, MD, is the 2018 recipient of the New Investigator Award from the American Medical Informatics Association (AMIA). -
October 25, 2018
Mary Kay Foundation grant to bolster immunotherapy research
An immunotherapy research initiative at Vanderbilt University Medical Center is among those being supported by the Mary Kay Foundation, which has announced $1.2 million in funding that will be equally shared among 12 cancer research institutions.